SI Group Announces Closing of Comprehensive Recapitalization, Positioning the Company for Accelerated Growth
Significant De-leveraging Transaction Resulting in Overall Debt Reduction of Approximately $1.7 Billion…
Best Peptides for Muscle Growth: Prescription Sermorelin Access, Injectable vs. Dissolving Tablets, and Realistic Expectations
AUSTIN, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for…
U.S. FDA Approves Agios AQVESME (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and…
Bybit Unveils Mantle Vault: Yield-Bearing, Flexible, and Built for Scalable Stablecoin Returns
DUBAI, UAE, Dec. 23, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange…
Comviva & Global Money Exchange win IBSi Global FinTech Innovation Award for Transforming Cross-Border Payments
NEW DELHI, Dec. 23, 2025 /PRNewswire/ -- Comviva, the global leader in…
Zoomcar Calls for Experience-Led EV Adoption as India Prepares for a Breakthrough Year in 2026
Self-drive rentals can bridge the 'EV Experience Gap', accelerating nationwide adoption.BENGALURU, India,…
Curium Announces First Commercial Doses of PYLCLARI for Patients with Prostate Cancer in Poland
PYLCLARI® provides solutions to a wider patient group across Poland where there…
Press Release: Sanofi and Regenerons Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to…
Dupixent (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
Approval based on global Phase 3 program in children demonstrating Dupixent significantly…
Distech Controls Recognized with Frost & Sullivan’s 2025 Global Company of the Year for Excellence in Integrated Smart Building Solutions
The company is recognized for its innovation-driven strategy, strong execution, and global…
